KRTAP22-1
gene geneOn this page
Also known as KAP22.1
Summary
KRTAP22-1 (keratin associated protein 22-1, HGNC:18947) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 22-1 (Q3MIV0). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337979 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_181620
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18947 |
| Approved symbol | KRTAP22-1 |
| Name | keratin associated protein 22-1 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP22.1 |
| Ensembl gene | ENSG00000186924 |
| Ensembl biotype | protein_coding |
| Entrez | 337979 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334680
RefSeq mRNA: 1 — MANE Select: NM_181620
NM_181620
CCDS: CCDS13601
Canonical transcript exons
ENST00000334680 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337805 | 30601087 | 30601382 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 94.37.
Top tissues by expression
110 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.37 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.19 | silver quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| leukocyte | CL:0000738 | 25.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| monocyte | CL:0000576 | 25.78 | gold quality |
| right lobe of liver | UBERON:0001114 | 25.02 | silver quality |
| muscle of leg | UBERON:0001383 | 24.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| kidney | UBERON:0002113 | 24.01 | silver quality |
| frontal cortex | UBERON:0001870 | 23.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 22-1 — Q3MIV0 (reviewed: Q3MIV0)
All UniProt accessions (1): Q3MIV0
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
RefSeq proteins (1): NP_853651* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
| IPR052878 | KRTAP_matrix | Family |
Pfam: PF11759
UniProt features (3 total): sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3MIV0-F1 | 41.02 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 8 (showing top):
AACTTT_UNKNOWN, chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
112 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP22-1 | KRTAP20-1 | Q3LI63 | 881 |
| KRTAP22-1 | KRTAP6-3 | Q3LI67 | 881 |
| KRTAP22-1 | KRTAP20-2 | Q3LI61 | 877 |
| KRTAP22-1 | KRTAP6-1 | Q3LI64 | 877 |
| KRTAP22-1 | KRTAP15-1 | Q3LI76 | 849 |
| KRTAP22-1 | KRTAP24-1 | Q3LI83 | 846 |
| KRTAP22-1 | KRTAP26-1 | Q6PEX3 | 840 |
| KRTAP22-1 | KRTAP6-2 | Q3LI66 | 795 |
| KRTAP22-1 | KRTAP13-3 | Q3SY46 | 795 |
| KRTAP22-1 | SCYGR1 | A0A286YEY9 | 794 |
| KRTAP22-1 | KRTAP8-1 | Q8IUC2 | 765 |
| KRTAP22-1 | KRTAP7-1 | Q8IUC3 | 708 |
| KRTAP22-1 | KRTAP11-1 | Q8IUC1 | 693 |
| KRTAP22-1 | KRTAP21-1 | Q3LI58 | 666 |
| KRTAP22-1 | KRTAP13-1 | Q8IUC0 | 662 |
IntAct
0 interactions, top by confidence:
BioGRID (14): KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), KRTAP22-1 (Two-hybrid), ARID5A (Two-hybrid)
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
97 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30601183:C:G | donor_gain | 0.8700 |
| 21:30601167:G:GT | donor_gain | 0.8200 |
| 21:30601154:GGC:G | donor_gain | 0.8000 |
| 21:30601234:T:TG | donor_gain | 0.7700 |
| 21:30601148:G:GA | donor_gain | 0.7500 |
| 21:30601204:C:G | donor_gain | 0.7500 |
| 21:30601147:T:TA | donor_gain | 0.7400 |
| 21:30601231:GTGT:G | donor_gain | 0.7400 |
| 21:30601232:TGTT:T | donor_gain | 0.7400 |
| 21:30601203:GC:G | donor_gain | 0.7000 |
| 21:30601233:G:GA | donor_gain | 0.7000 |
| 21:30601193:G:GA | donor_gain | 0.6900 |
| 21:30601098:C:G | donor_gain | 0.6600 |
| 21:30601170:GCC:G | donor_gain | 0.6600 |
| 21:30601166:G:GT | donor_gain | 0.6100 |
| 21:30601229:T:A | donor_gain | 0.6100 |
| 21:30601239:A:T | donor_gain | 0.6100 |
| 21:30601192:T:TA | donor_gain | 0.6000 |
| 21:30601121:A:G | donor_gain | 0.5800 |
| 21:30601155:GC:G | donor_gain | 0.5800 |
| 21:30601209:GC:G | donor_gain | 0.5800 |
| 21:30601210:C:G | donor_gain | 0.5800 |
| 21:30601098:C:CG | donor_gain | 0.5600 |
| 21:30601234:T:G | donor_gain | 0.5600 |
| 21:30601195:T:TA | donor_gain | 0.5500 |
| 21:30601345:GA:G | acceptor_gain | 0.5500 |
| 21:30601126:C:G | donor_gain | 0.5400 |
| 21:30601230:GGTGT:G | donor_gain | 0.5400 |
| 21:30601219:C:G | donor_gain | 0.5200 |
| 21:30601337:T:A | acceptor_gain | 0.5200 |
AlphaMissense
311 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30601262:T:C | F48L | 0.796 |
| 21:30601264:C:A | F48L | 0.796 |
| 21:30601264:C:G | F48L | 0.796 |
| 21:30601250:T:C | F44L | 0.770 |
| 21:30601252:T:A | F44L | 0.770 |
| 21:30601252:T:G | F44L | 0.770 |
| 21:30601127:T:C | F3L | 0.750 |
| 21:30601129:T:A | F3L | 0.750 |
| 21:30601129:T:G | F3L | 0.750 |
| 21:30601247:T:A | W43R | 0.664 |
| 21:30601247:T:C | W43R | 0.664 |
| 21:30601249:G:C | W43C | 0.660 |
| 21:30601249:G:T | W43C | 0.660 |
| 21:30601234:T:G | C38W | 0.623 |
dbSNP variants (sampled 300 via entrez): RS1000270364 (21:30599228 A>C,G), RS1001937248 (21:30600540 C>T), RS1002154218 (21:30599353 T>C), RS1005735454 (21:30600017 A>G), RS1006181093 (21:30599722 A>G), RS1006775426 (21:30600893 A>G), RS1006916663 (21:30599979 C>T), RS1008849905 (21:30600846 C>G), RS1009690309 (21:30599429 A>T), RS1012457091 (21:30599145 A>C), RS1013366793 (21:30600125 G>A), RS1013721326 (21:30600520 G>A), RS1014190000 (21:30600296 A>C,T), RS1017198077 (21:30599735 A>C), RS1017541189 (21:30600018 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.